Testing for SARS-CoV-2: lessons learned and current use cases.
Theel, Elitza S, James E Kirby, and Nira R Pollock. 2024. “Testing for SARS-CoV-2: Lessons Learned and Current Use Cases.”. Clinical Microbiology Reviews 37 (2): e0007223.
Search
Search results
89 results found
Evaluation of the Abbott Alinity m STI assay for diagnosis of the primary causes of sexually transmitted infections in the United States.
Matysiak, Colette, Annie Cheng, and James E Kirby. 2023. “Evaluation of the Abbott Alinity M STI Assay for Diagnosis of the Primary Causes of Sexually Transmitted Infections in the United States.”. Practical Laboratory Medicine 36: e00332.
Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome.
Morgan, Christopher E, Yoon-Suk Kang, Alex B Green, Kenneth P Smith, Matthew G Dowgiallo, Brandon C Miller, Lucius Chiaraviglio, et al. 2023. “Streptothricin F Is a Bactericidal Antibiotic Effective Against Highly Drug-Resistant Gram-Negative Bacteria That Interacts With the 30S Subunit of the 70S Ribosome.”. PLoS Biology 21 (5): e3002091.
The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.
Arnaout, Ramy, Rose A Lee, Ghee Rye Lee, Cody Callahan, Annie Cheng, Christina F Yen, Kenneth P Smith, Rohit Arora, and James E Kirby. 2021. “The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.”. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 73 (9): e3042-e3046.
Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus.
Cheng, Annie, Stefan Riedel, Ramy Arnaout, and James E Kirby. 2022. “Verification of the Abbott Alinity M Resp-4-Plex Assay for Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus.”. Diagnostic Microbiology and Infectious Disease 102 (2): 115575.
Combating Antimicrobial Resistance Through Student-Driven Research and Environmental Surveillance.
Fuhrmeister, Erica R, Jennifer R Larson, Adam J Kleinschmit, James E Kirby, Amy J Pickering, and Carol A Bascom-Slack. 2021. “Combating Antimicrobial Resistance Through Student-Driven Research and Environmental Surveillance.”. Frontiers in Microbiology 12: 577821.
Microwave-Generated Steam Decontamination of N95 Respirators Utilizing Universally Accessible Materials.
Zulauf, Katelyn E, Alex B Green, Alex N Nguyen Ba, Tanush Jagdish, Dvir Reif, Robert Seeley, Alana Dale, and James E Kirby. 2020. “Microwave-Generated Steam Decontamination of N95 Respirators Utilizing Universally Accessible Materials.”. MBio 11 (3).
Reply to Humphries and Simner, "Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance," and Wojewoda et al., "College of American Pathologists (CAP) Microbiology Committee Perspective: the Need for Verification Studies".
Kirby, James E, Thea Brennan-Krohn, and Kenneth P Smith. 2020. “Reply to Humphries and Simner, "Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance," and Wojewoda et Al., ‘College of American Pathologists (CAP) Microbiology Committee Perspective: The Need for Verification Studies’.”. Journal of Clinical Microbiology 58 (4).
New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.
Brennan-Krohn, Thea, Roman Manetsch, George A O’Doherty, and James E Kirby. 2020. “New Strategies and Structural Considerations in Development of Therapeutics for Carbapenem-Resistant Enterobacteriaceae.”. Translational Research : The Journal of Laboratory and Clinical Medicine 220: 14-32.
A Whole-Cell Screen for Adjunctive and Direct Antimicrobials Active against Carbapenem-Resistant Enterobacteriaceae.
Smith, Kenneth P, Matthew G Dowgiallo, Lucius Chiaraviglio, Prakash Parvatkar, Chungsik Kim, Roman Manetsch, and James E Kirby. 2019. “A Whole-Cell Screen for Adjunctive and Direct Antimicrobials Active Against Carbapenem-Resistant Enterobacteriaceae.”. SLAS Discovery : Advancing Life Sciences R & D 24 (8): 842-53.